n
S. pneumonia(N=16)
S. pyogens(N=8)
P. aeruginosa(N=6)
K. pneumonia (N=4)
E.coli (N=2)
Staph. Aureus (N=2)
H. influenza (N=3)
Total
S
M
R
S
M
R
S
M
R
S
M
R
S
M
R
S
M
R
S
M
R
S
M
R
Piperacillin + tazobactum
41
15
0
1
7
1
0
6
0
0
4
0
0
2
0
0
1
0
1
3
0
0
38
1
2
Amoxycillin
29
7
2
7
4
1
3
0
0
0
0
0
0
0
0
0
0
0
2
2
0
1
13
3
13
Co-amoxyclav
29
9
3
4
3
1
4
0
0
0
0
0
0
0
0
0
1
0
1
3
0
0
16
4
9
Amikacin
14
0
0
0
0
0
0
5
0
0
3
0
1
2
0
0
0
0
0
3
0
0
13
0
1
Gentamicin
15
0
0
0
0
0
0
3
2
1
2
2
0
1
0
1
0
0
0
0
1
2
6
5
4
Tobramicin
15
0
0
0
0
0
0
4
1
1
2
0
2
1
1
0
0
0
0
2
1
0
9
3
3
Ciprofloxacin
40
9
0
6
5
0
3
3
0
3
4
0
0
1
0
1
0
0
2
2
1
0
24
1
15
Levofloxacin
15
0
0
0
0
0
0
3
0
3
4
0
0
1
0
1
0
0
0
2
0
1
10
0
5
Ofloxacin
41
7
2
7
5
0
3
3
0
3
3
1
0
1
0
1
0
0
2
2
1
0
21
4
16
Norfloxacin
13
0
0
1
0
0
0
3
0
3
4
0
0
1
0
1
0
0
0
0
0
0
8
0
5
Azithromycin
29
10
1
5
5
2
1
0
0
0
0
0
0
0
0
0
1
0
1
1
1
1
17
4
8
Roxithromycin
21
6
0
2
3
0
5
0
0
0
0
0
0
0
0
0
0
0
2
0
1
2
9
1
11
Clarithromycin
21
4
2
2
3
0
5
0
0
0
0
0
0
0
0
0
0
0
2
0
1
2
7
3
11
Erythromycin
29
4
1
11
3
0
5
0
0
0
0
0
0
0
0
0
0
0
2
0
0
3
7
1
21
Vancomicin
20
5
0
4
1
0
5
0
0
0
0
0
0
0
0
0
1
1
0
0
0
3
7
1
12
Clindamicin
20
5
0
4
2
0
4
0
0
0
0
0
0
0
0
0
0
0
2
0
0
3
7
0
13
Linezolid
20
7
1
1
2
0
4
0
0
0
0
0
0
0
0
0
0
0
2
0
0
3
9
1
10
Imipenem
14
0
0
0
0
0
0
2
0
3
4
0
0
2
0
0
0
0
0
2
1
0
10
1
3
Meropenem + cilastatin
15
0
0
0
0
0
0
6
0
0
4
0
0
2
0
0
0
0
0
3
0
0
15
0
0
Ceftriaxone
15
0
0
0
0
0
0
3
0
3
3
0
1
1
0
1
0
0
0
3
0
0
10
0
5
Cefixime
15
0
0
0
0
0
0
1
0
5
1
0
3
0
0
2
0
0
0
0
1
2
2
1
12
Cefoperazone + sulbactum
15
0
0
0
0
0
0
6
0
0
4
0
0
2
0
0
0
0
0
2
1
0
14
1
0
Cefotaxime
15
0
0
0
0
0
0
3
0
3
3
0
1
1
0
1
0
0
0
2
1
0
9
1
5
Cefadroxil
20
6
0
2
3
0
4
0
0
0
0
0
0
0
0
0
0
0
2
0
1
2
9
1
10
Cefpodoxime
16
0
0
1
0
0
0
0
0
6
1
0
3
0
0
2
0
0
0
2
1
0
3
1
12
Cefuroxime
37
7
1
6
3
0
4
1
0
5
1
2
1
0
1
1
0
0
1
0
1
2
12
5
20
Table 2:
Drug sensitivity pattern of various pathogens isolated from sputum (n=total number of patients tested, S=sensititve, M=moderately sensitive, R=resistant).